D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 9.69% |
| 2 | Consumer Discretionary | 9.53% |
| 3 | Technology | 9.28% |
| 4 | Healthcare | 8.29% |
| 5 | Financials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HGG
2001
DELISTED
hhgregg Inc.
HGG
| $1.97M | ﹤0.01% |
322,096
-17,272
| -5% | -$105K |
|
2002
Intrepid Potash
IPI
$474M
| $1.97M | ﹤0.01% |
17,086
+2,372
| +16% | +$312K |
|
2003
PUT
Melco Resorts & Entertainment
MLCO
$2.19B
| $1.96M | ﹤0.01% |
91,400
-522,400
| -85% | -$12.5M |
|
|
NPBC
2004
DELISTED
NATL PENN BANCSHARES INC
NPBC
| $1.96M | ﹤0.01% |
182,003
-67,964
| -27% | -$710K |
|
2005
PUT
Electronic Arts
EA
$52.4B
| $1.96M | ﹤0.01% |
33,300
-30,100
| -47% | -$1.62M |
|
|
JOY
2006
CALL
DELISTED
Joy Global Inc
JOY
| $1.96M | ﹤0.01% |
50,000
-30,000
| -38% | -$1.27M |
|
|
SZMK
2007
DELISTED
SIZMEK INC COM STK (DE)
SZMK
| $1.96M | ﹤0.01% |
269,811
+23,116
| +9% | +$162K |
|
|
LCI
2008
PUT
DELISTED
Lannett Company, Inc.
LCI
| $1.96M | ﹤0.01% |
+7,225
| New | +$1.64M |
|
|
IL
2009
DELISTED
IntraLinks Holdings Inc.
IL
| $1.95M | ﹤0.01% |
188,643
+16,847
| +10% | +$185K |
|
|
GEVA
2010
CALL
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $1.95M | ﹤0.01% |
+20,000
| New | +$2.12M |
|
2011
PUT
Cameco
CCJ
$37.9B
| $1.95M | ﹤0.01% |
140,000
-83,900
| -37% | -$1.25M |
|
|
ANN
2012
CALL
DELISTED
ANN INC
ANN
| $1.95M | ﹤0.01% |
47,400
| – | – |
|
|
FBC
2013
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $1.94M | ﹤0.01% |
133,631
+9,173
| +7% | +$137K |
|
|
CEMP
2014
DELISTED
Cempra, Inc.
CEMP
| $1.94M | ﹤0.01% |
+56,472
| New | +$1.7M |
|
|
CTLT
2015
DELISTED
CATALENT, INC.
CTLT
| $1.94M | ﹤0.01% |
62,121
+8,772
| +16% | +$253K |
|
|
JOY
2016
PUT
DELISTED
Joy Global Inc
JOY
| $1.94M | ﹤0.01% |
49,400
-74,700
| -60% | -$3.17M |
|
2017
ResMed
RMD
$30.3B
| $1.93M | ﹤0.01% |
26,892
+13,988
| +108% | +$909K |
|
2018
PUT
Capital One
COF
$130B
| $1.92M | ﹤0.01% |
24,400
-59,800
| -71% | -$4.7M |
|
|
CASC
2019
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $1.92M | ﹤0.01% |
196,524
+40,449
| +26% | +$397K |
|
|
INWK
2020
DELISTED
InnerWorkings, Inc.
INWK
| $1.92M | ﹤0.01% |
285,856
-60,322
| -17% | -$378K |
|
2021
PUT
Best Buy
BBY
$18.9B
| $1.92M | ﹤0.01% |
50,800
-141,900
| -74% | -$5.43M |
|
|
CBL
2022
DELISTED
CBL& Associates Properties, Inc.
CBL
| $1.92M | ﹤0.01% |
96,833
-292,693
| -75% | -$5.9M |
|
2023
CALL
Dollar General
DG
$27.8B
| $1.92M | ﹤0.01% |
25,400
-10,000
| -28% | -$707K |
|
2024
Cato Corp
CATO
$67.3M
| $1.91M | ﹤0.01% |
48,345
+7,480
| +18% | +$318K |
|
2025
Essent Group
ESNT
$6.21B
| $1.91M | ﹤0.01% |
+79,957
| New | +$1.92M |
|
Similar funds
D.E. Shaw & Co's Q1 2015 Portfolio in Review
As of Q1 2015, D.E. Shaw & Co held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 9.7% of assets, up from 8% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, D.E. Shaw & Co opened a new position in SPDR Gold Trust worth $231M.
- D.E. Shaw & Co's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- D.E. Shaw & Co's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- D.E. Shaw & Co fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- D.E. Shaw & Co opened 448 new positions and closed 828 in Q1 2015.
- D.E. Shaw & Co's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.